Dopaminergic neuron proliferative progenitor cell marker Nato3

Details Dopaminergic neuron proliferative progenitor cell marker Nato3 Dopaminergic neuron proliferative progenitor cell marker Nato3

2006-08-18

2011-11-29

Ulm, John (Department: 1649)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C536S024310

Reexamination Certificate

active

08067161

ABSTRACT:
The present invention is a probe, a primer, and an antibody, for detecting a dopaminergic neuron proliferative progenitor cell. According to the present invention, there is provided a polynucleotide probe and a polynucleotide primer for use in the detection or selection of a dopaminergic neuron proliferative progenitor cell, which can hybridize with a polynucleotide consisting of a nucleotide sequence of a Nato3 gene, or a complementary sequence thereto, and an antibody against a Nato3 protein, or a part thereof for use in the detection or selection of a dopaminergic neuron proliferative progenitor cell.

REFERENCES:
patent: 5690927 (1997-11-01), Major et al.
patent: 6277820 (2001-08-01), Rosenthal et al.
patent: 2005/0175997 (2005-08-01), Ono et al.
patent: 2006/0239978 (2006-10-01), Nakagawa et al.
patent: 2006/0240432 (2006-10-01), Ono et al.
patent: 2007/0122882 (2007-05-01), Nakagawa et al.
patent: 2007/0254281 (2007-11-01), Ono et al.
patent: 2008/0280301 (2008-11-01), Ono et al.
patent: 2010/0203505 (2010-08-01), Ono et al.
patent: 2002-51775 (2002-02-01), None
patent: WO 94/23754 (1994-10-01), None
patent: WO 95/12982 (1995-05-01), None
patent: WO 96/14398 (1995-05-01), None
patent: WO 96/14399 (1995-05-01), None
patent: WO 96/14397 (1996-05-01), None
patent: WO 96/28030 (1996-09-01), None
patent: WO 96/28174 (1996-09-01), None
patent: WO 96/39496 (1996-12-01), None
patent: WO 97/02049 (1997-01-01), None
patent: WO 99/43286 (1999-09-01), None
patent: WO 99/56759 (1999-11-01), None
patent: WO 99/64608 (1999-12-01), None
patent: WO 00/06700 (2000-02-01), None
patent: WO 00/09669 (2000-02-01), None
patent: WO 01/57194 (2001-08-01), None
patent: WO 02/074906 (2002-09-01), None
patent: WO 02/103007 (2002-12-01), None
patent: WO 2004/038018 (2004-05-01), None
patent: WO 2004/065599 (2004-08-01), None
patent: WO 2005/052190 (2005-06-01), None
patent: WO 2007/021004 (2007-02-01), None
Segev, E., et al., “Nato3 is an evolutionarily conserved bHLH transcription factor expressed in the CNS ofDrosophilaand mouse,”Mechanisms of Development, vol. 106, pp. 197-202 (2001).
Guillemot, F., “Vertebrate bHLH Genes and the Determination of Neuronal Fates,”Experimental Cell Research, vol. 253, pp. 357-364 (1999).
Kawasaki, H., et al., “Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell-Derived Inducing Activity,”Neuron, vol. 28, pp. 31-40 (Oct. 2000).
Kele, J., et al., “Function of proneural bHLH genes in ventral midbrain dopaminergic neurogenesis,”Mechanisms of Development; Abstracts of the 15thInternational Society of Developmental Biologists Congress 2005, vol. 122 (Supplement 1), p. S181, Abstract 15—P021 (Jul. 12, 2005).
Verzi, M., et al., “N-Twist, an Evolutionarily Conserved bHLH Protein Expressed in the Developing CNS, Functions as a Transcriptional Inhibitor,”Developmental Biology, vol. 249, pp. 174-190 (2002).
Wallén, A., et al., “Transcriptional Control of Dopamine Neuron Development,”Ann. N.Y. Acad. Sci., vol. 991, pp. 48-60 (Jun. 1, 2003).
PCT International Preliminary Report on Patentability (Chapter I) issued for PCT/JP2006/316249 on Feb. 28, 2008, 5 pgs.
Barberi, T., et al., “Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice,”Nat. Biotechnol., vol. 21(10), pp. 1200-1207 (Oct. 2003).
Bjorklund, L. M., et al., “Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model,”Proc. Nat'l Acad. Sci. U.S.A., vol. 99(4), pp. 2344-2349 (Feb. 19, 2002).
Defer, G. L., et al., “Long-term outcome of unilaterally transplanted parkinsonian patients,”Brain, vol. 119, pt.1, pp. 41-50 (Feb. 1996).
Freed, C. R., et al., “Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease,”N. Engl. J. Med., vol. 327(22), pp. 1549-1555 (Nov. 26, 1992).
Hooper, J. D., et al., “Localization of the mosaic transmembrane serine protease corin to heart myocytes,”Eur. J. Biochem., vol. 267(23), pp. 6931-6937 (Dec. 2000).
Kawasaki, H., et al., “Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity,”Proc. Nat'l Acad. Sci. U.S.A., vol. 99(3), pp. 1580-1585 (Feb. 5, 2002).
Kim, J. H., et al., “Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease,”Nature, vol. 418(6893), pp. 50-56 (Jul. 4, 2002).
Kordower, J. H., et al., “Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease,”N. Engl. J. Med., vol. 332(17), pp. 1118-1124 (Apr. 27, 1995).
Lee, S. H., et al., “Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells,”Nat. Biotechnol., vol. 18(6), pp. 675-679 (Jun. 2000).
Lindvall, O., et al., “Human Fetal Dopamine Neurons Grafted Into the Striatum in Two Patients With Severe Parkinson's Disease,”Aroh. Neurol. vol. 46(6), pp. 615-631 (Jun. 1989).
Lopez-Lozano, J. J., et al., “Regression of Parkinsonian Fetal Ventral Mesencephalon Grafts Upon Withdrawal of Cyclosporine A Immunosuppression,”Transplant Proc., vol. 29(1-2), pp. 977-980 (Feb.-Mar. 1997).
Sakamoto, Y., et al., “The candidate of cell surface marker of dopaminergic progenitor cells,” Proceedings of the 27thAnnual meeting of the Molecular Biology Society of Japan, p. 762 (Nov. 25, 2004) 2PB-250.
Sawamoto, K., et al., “Generation of Dopaminergic Neurons in the Adult Brain from Mesencephalic Precursor Cells Labeled with anestin-GFPTransgene,”J. Neurosci, vol. 21(11), pp. 3895-3903 (Jun. 1, 2001).
Sawamoto, K., et al., “Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons,”Proc. Nat'l Acad. Sci. U.S.A., vol. 98(11), pp. 6423-6428 (May 2001).
Selawry, H. P., et al., “Sertoli Cell-Enriched Fractions in Successful Islet Cell Transplantation,”Cell Transplant, vol. 2(2), pp. 123-129 (1993).
Spencer, D. D., et al., “Unilateral Transplantation of Human Fetal Mesencephalic Tissue into the Caudate Nucleus of Patients with Parkinson's Disease,”N. Engl. J. Med., vol. 327(22), pp. 1541-1548 (Nov. 26, 1992).
Studer, L., et al., “Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats,”Nat. Neurosci., vol. 1(4), pp. 290-295 (1998).
Winder, H., et al., “Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP),”N. Engl. J. Med., vol. 327(22), pp. 1556-1563 (Nov. 26, 1992).
Yan, W., et al., “Corin, a Mosaic Transmembrane Serine Protease Encoded by a Novel cDNA from Human Heart,”J. Biol. Chem., vol. 274(21), pp. 14926-14935 (May 21, 1999).
Yoshizaki, T., et al., “Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells,”Neurosci. Lett., vol. 363(1), pp. 33-37 (2004).
Zhao, S., et al., “Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons,”Eur. J. Neurosci., vol. 19(5), pp. 1133-1140 (2004).
Japanese Office action dated Jul. 15, 2011, issued in related Japanese Patent Application No. 2007-531040.
Japanese Patent Application No. 2007-531041, entered Feb. 14, 2008, corresponding to U.S. Patent Publication No. 2010/203505, published Aug. 12, 2010 and published as WO 2007/021004 on Feb. 22, 2007.

Affiliated with

Also associated with

Rating

Dopaminergic neuron proliferative progenitor cell marker Nato3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dopaminergic neuron proliferative progenitor cell marker Nato3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopaminergic neuron proliferative progenitor cell marker Nato3 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4289573